Riskpilot← Back to searchSign inGet full accessCelluCircle AB
ABActiveOrg 5593839722Sothönevägen 10Technical testing and analysis · NACE 7120Est. 20225-9 employees
Revenue 2025
SEK 0
EBITDA margin
—
-321% vs 2024
Equity ratio
67.3%
Financial strength
Net profit 2025
SEK -1,6M
-337% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -1,5M | -321% |
| Net profit | SEK -1,6M | -337% |
| Total assets | SEK 7,1M | +3849% |
| Equity | SEK 4,8M | +5524% |
| Employees | — | — |
Legal name
CelluCircle AB
Org number
5593839722
Legal form
Aktiebolag
NACE code
7120 · Technical testing and analysis
Founded
7 juni 2022
Share capital
SEK 34 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Förtaget ska utveckla och kommersialisera teknologier för textilåtervinning och användning av återvunnen (nano)cellulosa i 3D-tryckta produkter samt bedriva därmed förenlig verksamhet.
Address
Sothönevägen 10
Email
aji.mathew@cellucircle.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 0 | 40 | 0 |
| Staff expenses | — | — | — |
| EBITDA | −84 | −364 | −1 529 |
| Depreciation & amort. | −0 | — | −0 |
| EBIT | −84 | −364 | −1 529 |
| Net financials | 1 | 6 | −31 |
| Profit before tax | −83 | −357 | −1 560 |
| Tax | −0 | — | −0 |
| Net profit | −83 | −357 | −1 560 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 533 | 179 | 7 079 |
| Equity | 442 | 85 | 4 762 |
| Long-term debt | 0 | — | 340 |
| Short-term debt | 91 | 95 | 1 977 |
| Total debt | 91 | 95 | 2 317 |
EBITDA margin
-152900000.0%
This company
15.8%
Market median
-967721619% vs market
20232025
Equity ratio
67.3%
This company
38.2%
Market median
+76% vs market
20232025
Return on equity
-32.8%
This company
18.4%
Market median
-278% vs market
20232025
Net profit margin
-156000000.0%
This company
8.1%
Market median
-1925926026% vs market
20232025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20232025
Debt / equity
0.49×
This company
0.62×
Market median
+21% vs market
20232025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-06-01 – 2023-03-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TH Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
JF Chief Auditor | Chief Auditor | 2025 | — | — |
VA Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2024 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CelluCircle AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tomas Hjort | Chief Executive Officer | 0 companies |
| Jonas Fredrik Mårtensson | Chief Auditor | 0 companies |
| Varvara Apostolopoulou Kalkavoura | Chief Executive Officer | 0 companies |
| Jan Magnus Fransson | Board of Directors | 0 companies |
| Pradeep George Koshy | Board of Directors | 0 companies |
| Ellen Mona Gratia Wilcke | Chairman | 0 companies |
| Ioannis Mytilinaios | Board of Directors | 0 companies |
| Aji Pallikunnel Mathew | Board of Directors | 0 companies |
| Nils Markus Åkerstedt | Chairman | 0 companies |